Contents: Original Research
White, Kari PhD, MPH; Teal, Stephanie B. MD, MPH; Potter, Joseph E. PhD
Department of Health Care Organization & Policy, University of Alabama at Birmingham, Birmingham, Alabama; the Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, Colorado; and the Population Research Center, University of Texas at Austin, Austin, Texas.
Corresponding author: Kari White, PhD, MPH, Health Care Organization & Policy, University of Alabama at Birmingham, 1720 2nd Avenue N, RPHB 320, Birmingham, AL 35294; e-mail: [email protected].
Infrastructural support for the study was provided by a grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R24 042849) to the Population Research Center, University of Texas at Austin.
Financial Disclosure Dr. Teal has served on the scientific advisory boards of Actavis, Bayer Healthcare, and MicroCHIPs and the Data Safety and Monitoring Board for a Phase 4 study required by the U.S. Food and Drug Administration and funded by Merck; she also has received research support from Medicines360. The other authors did not report any potential conflicts of interest.
